N-(3-methoxypropyl)-1-methyl-4-piperidinamine disuccinate, 95.0%, 25g

2-Methyl-6-(trifluoromethyl)quinoline, 97%, 250mg

(E)-3-(1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acrylic acid, 100mg

(3-Cyano-2,4-difluorophenyl)boronic acid, 95.0%, 10g

Embudo de separación según. a Gilson, 250 ml, 2 Pieza(s)

2-(2-(2-FLUOROPHENYL)-2-OXOETHYL)MALONONITRILE, 97%, 5g

1H,3H-Furo[3,4-c]furan, 1-(3,4-dimethoxyphenyl)tetrahydro-4-(3,4,5-trimethoxyphenyl)-, (1S,3aR,4S,6aR)-, 98%, 50mg

5-(4-(1,2,2-Triphenylvinyl)phenyl)thiophene-2-carbaldehyde, 98%, 5g

4-Aminocinnoline, 96%, 1g

2,3-Difluoro-4-[(trans-4-propylcyclohexyl)methoxy]anisole>98.0%(GC)5g

Monosodium Succinate>98.0%(T)25g

2-Chloro-7-iodo-5H-pyrrolo[3,2-d]pyrimidine, 95.0%, 100mg

3-Chloro-2-fluoroisonicotinaldehyde, 95.0%, 250mg